Seer Inc News - SEER

Professional-Grade Tools, for Individual Investors.

Current Report Filing (8-k)

FALSE000172644500017264452022-02-182022-02-18UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...

Statement of Ownership (sc 13g)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name...

Amended Statement of Ownership (sc 13g/a)

SCHEDULE 13G Amendment No. 1 SEER INC CLASS A COMMON STOCK Cusip #81578P106 Check the appropriate box to designate...

Statement of Ownership (sc 13g)

us81578p1066_020422.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Statement of Ownership (sc 13g)

dXM4MTU3OHAxMDY2XzAyMDQyMi50eHQKClNFQ1VSSVRJRVMgQU5EIEVYQ0hBTkdFIENPTU1JU1NJ T04KCldhc2hpbmd0b24sIEQuQy4gMjA1NDkKClNDSEVEVUxFIDEzRwoKVW5kZXIgd...

Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021

REDWOOD CITY, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company...

Current Report Filing (8-k)

FALSE000172644500017264452022-01-182022-01-18 UNITED STATES SECURITIES AND...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

REDWOOD CITY, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company...

Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies

- Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296...

Monksdream 1 week ago

SEER under $2

👍️0

Monksdream 3 weeks ago

SEER under $2

👍️0

Monksdream 3 months ago

SEER under $2

👍️0

Monksdream 4 months ago

SEER under $2

👍️0

Monksdream 5 months ago

SEER under $2

👍️0

Monksdream 9 months ago

SEER new 52 week low

👍️0

Monksdream 9 months ago

SEER under $2

👍️0

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Seer Inc (SEER)

Professional-Grade Tools, for Individual Investors.

SEER News

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies

Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies

SEER Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Seer Inc (SEER) News

Seer Inc (SEER)

Professional-Grade Tools, for Individual Investors.

SEER News

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies

Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies

SEER Discussion

Your Recent History